Treatment aims to eradicate *H. pylori*, reduce the risk of peptic ulcer disease, ulcer bleeding, gastric malignancy, and recurrence of gastritis and peptic ulcers.
About
- First discovered by Barry Marshall in 1982.
- The most common cause of peptic ulceration, though many carriers remain asymptomatic.
- Present in 95% of duodenal ulcers and 70–80% of gastric ulcers.
- NSAIDs may exacerbate ulceration if co-infection with *H. pylori* exists.
- Associated with acute and chronic gastritis, gastric cancer, and mucosa-associated lymphoid tissue (MALT) lymphoma.
Electron Microscopy
Source
- Likely spreads person-to-person through oral or faeco-oral routes.
- More common in older patients and in lower socioeconomic environments.
- The primary reservoir is humans, although *H. pylori* has also been found in cats.
Characteristics
- Spiral-shaped, gram-negative, highly motile bacillus.
- Microaerophilic organism with 4 to 6 unipolar flagella and urease production.
- Adheres to gastric epithelial cells and resides beneath the mucous layer of the stomach lining.
Virulence
- Triggers localized neutrophilic gastritis.
- Presence of the *cagA* gene (cytotoxin-associated gene) is linked to more severe disease manifestations.
Pathogenicity
- Antral gastritis leading to achlorhydria, raised gastrin levels, and increased acid secretion.
- Chronic duodenal ulcers in over 95% of cases.
- Gastric ulcers in over 80% of cases.
- Associated with gastric adenocarcinoma (over 80%) and MALT lymphoma, which may regress with *H. pylori* eradication.
Investigations
- Serology: Detects IgG antibodies but cannot differentiate between current or past infection.
- Carbon urea breath test (using 13C or 14C isotopes): Urease converts urea to labeled carbon dioxide, which is detected in expired breath—most accurate test.
- Stool Helicobacter Antigen Test (SAT): Can confirm active infection.
- Histology: High sensitivity and specificity when biopsies are examined under microscopy.
- Rapid urease tests (CLO test): Performed during endoscopy—cheap, fast, and specific.
- Culture: The gold standard, but slow and labor-intensive.
Management
- First-line treatment:
- Clarithromycin 500 mg twice daily for 1 week.
- Amoxicillin 1 g twice daily for 1 week.
- Omeprazole 20 mg twice daily for 2 weeks.
- Second-line treatment:
- Metronidazole for 1 week.
- Amoxicillin 1 g twice daily for 1 week.
- Omeprazole 20 mg twice daily for 2 weeks.
- Treatment is indicated for peptic ulcer disease and MALT lymphoma.
- Routine screening for asymptomatic *H. pylori* infection is not recommended in low-risk patients.
References